Protein phosphatase 2A mediates YAP activation in endothelial cells upon VEGF stimulation and matrix stiffness

• Verfasst von: Jiang, Xiao [VerfasserIn]
• Verfasst von: Hu, Jiandong [VerfasserIn]
• Verfasst von: Wu, Ziru [VerfasserIn]
• Verfasst von: Cafarello, Sarah Trusso [VerfasserIn]
• Verfasst von: Di Matteo, Mario [VerfasserIn]
• Verfasst von: Shen, Ying [VerfasserIn]
• Verfasst von: Dong, Xue [VerfasserIn]
• Verfasst von: Adler, Heike [VerfasserIn]
• Verfasst von: Mazzone, Massimiliano [VerfasserIn]
• Verfasst von: Ruiz de Almodóvar, Carmen [VerfasserIn]
• Verfasst von: Wang, Xiaohong [VerfasserIn]
• Titel: Protein phosphatase 2A mediates YAP activation in endothelial cells upon VEGF stimulation and matrix stiffness
• Verf.angabe: Xiao Jiang, Jiandong Hu, Ziru Wu, Sarah Trusso Cafarello, Mario Di Matteo, Ying Shen, Xue Dong, Heike Adler, Massimiliano Mazzone, Carmen Ruiz de Almodovar and Xiaohong Wang
• E-Jahr: 2021
• Jahr: 13 May 2021
• Umfang: 14 S.
• Fussnoten: Gesehen am 06.10.2021
• Titel Quelle: Enthalten in: Frontiers in cell and developmental biology
• Ort Quelle: Lausanne : Frontiers Media, 2013
• Jahr Quelle: 2021
• Band/Heft Quelle: 9(2021) vom: Mai, Artikel-ID 675562, Seite 1-14
• ISSN Quelle: 2296-634X
• DOI: doi:10.3389/fcell.2021.675562
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1772583642

Abstract

Angiogenesis is an essential process during development. Abnormal angiogenesis also contributes to many disease conditions such as tumor and retinal diseases. Previous studies have established the Hippo signaling pathway effector Yes-associated protein (YAP) as a crucial regulator of angiogenesis. In ECs, activated YAP promotes endothelial cell proliferation, migration and sprouting. YAP activity is regulated by vascular endothelial growth factor (VEGF) and mechanical cues such as extracellular matrix (ECM) stiffness. However, it is unclear how VEGF or ECM stiffness signal to YAP, especially how dephosphorylation of YAP occurs in response to VEGF stimulus or ECM stiffening. Here, we show that protein phosphatase 2A (PP2A) is required for this process. Blocking PP2A activity abolishes VEGF or ECM stiffening mediated YAP activation. Systemic administration of a PP2A inhibitor suppresses YAP activity in blood vessels in developmental and pathological angiogenesis mouse models. Consistently, PP2A inhibitor also inhibits sprouting angiogenesis. Mechanistically, PP2A directly interacts with YAP, and this interaction requires proper cytoskeleton dynamics. These findings identify PP2A as a crucial mediator of YAP activation in ECs and hence as an important regulator of angiogenesis.